|
Jasper Therapeutics, Inc. (JSPR) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Jasper Therapeutics, Inc. (JSPR) Bundle
Bewerten Sie die finanziellen Aussichten von Jasper Therapeutics, Inc. (JSPR) wie ein Experte! Dieser (JSPR) DCF-Taschenrechner ist mit vorgefüllten Finanzdaten ausgestattet und ermöglicht Ihnen die Flexibilität, das Umsatzwachstum, WACC, Margen und andere wesentliche Annahmen zu ändern, um Ihren Vorhersagen entsprechen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -31.9 | -31.2 | -38.2 | -65.0 | -76.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | .6 | 1.3 | 1.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -32.0 | -31.7 | -39.5 | -66.1 | -76.2 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 19.8 | 84.7 | 38.3 | 86.9 | 71.6 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | .0 | .0 | .3 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .1 | -.5 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.4 | 3.9 | 1.8 | 4.1 | 4.0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -2.4 | -.6 | -.3 | -.6 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -32.0 | -24.8 | -25.4 | -64.5 | -76.2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -31.2 | -23.0 | -27.3 | -61.5 | -76.7 | -4.0 | .0 | .0 | .0 | .0 |
| WACC, % | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | -70 | |||||||||
| Equity Value | 66 | |||||||||
| Diluted Shares Outstanding, MM | 14,585 | |||||||||
| Equity Value Per Share | 0.00 |
What You Will Get
- Pre-Filled Financial Model: Jasper Therapeutics’ actual data allows for accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, margins, WACC, and other vital drivers as needed.
- Instant Calculations: Automatic updates provide real-time results as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.
Key Features
- 🔍 Real-Life JSPR Financials: Pre-filled historical and projected data for Jasper Therapeutics, Inc. (JSPR).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Jasper’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Jasper’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Jasper Therapeutics data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Jasper Therapeutics’ intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Jasper Therapeutics, Inc. (JSPR)?
- Accurate Data: Real Jasper Therapeutics financials provide dependable valuation outcomes.
- Customizable: Modify essential parameters like growth projections, WACC, and tax rates to fit your estimates.
- Time-Saving: Pre-configured calculations remove the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotechnology sector.
- User-Friendly: Intuitive design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Jasper Therapeutics stock (JSPR).
- Financial Analysts: Enhance valuation processes with accessible and comprehensive financial models.
- Consultants: Provide clients with expert valuation insights quickly and with precision.
- Business Owners: Gain insights into how biotech companies like Jasper Therapeutics are valued to inform your own business strategy.
- Finance Students: Master valuation techniques using real-world data and industry scenarios.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Jasper Therapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Jasper Therapeutics, Inc. (JSPR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.